This article is being retracted from Bioscience Reports at the request of the Editor-in-Chief and the Editorial Board following receipt of a notification from a reader, alerting the Editorial Board to concerns regarding the western blots and flow-cytometry plots of this manuscript. The western blots have concerning features such as the shapes of the bands and absence of any detectable background, and the flow-cytometry plots of Figure 6E share strong similarities with those found in other papers by unrelated authors, including in Figures 2E and 4F of Li et al. 2019 (https://doi.org/10.1080/15384101.2019.1674071). The authors have been contacted with regards to these concerns and subsequently the retraction, but they have not responded to the Journal's queries or the concerns raised. Given the extent of the issues raised, the Editorial Board stand by the decision to retract the article.
Skip Nav Destination
Article navigation
February 2023
-
Cover Image
Cover Image
The cover of this issue of Bioscience Reports (Vol 43, Issue 02) features a representation of the anti-amyloidogenic effect exerted by inorganic, polymeric and organic nanoparticles against the fibrillation process of Aβ and consequent attenuation of associated neuroinflammation. Find out more about the impact of various nanoparticles on two important infectious diseases as well as cancer in the review article by Chakraborty et al.
Retraction|
February 10 2023
Retraction: MiR-486-3p inhibits the proliferation, migration and invasion of retinoblastoma cells by targeting ECM1 Open Access
Publisher: Portland Press Ltd
Online ISSN: 1573-4935
Print ISSN: 0144-8463
© 2023 The Author(s).
2023
This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).
Biosci Rep (2023) 43 (2): BSR-2020-0392_RET.
Connected Content
Citation
Retraction: MiR-486-3p inhibits the proliferation, migration and invasion of retinoblastoma cells by targeting ECM1. Biosci Rep 27 February 2023; 43 (2): BSR–2020–0392_RET. doi: https://doi.org/10.1042/BSR-2020-0392_RET
Download citation file:
894
Views
Cited By
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |